Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» COVID-19
COVID-19
Gilead stops Veklury study, citing enrollment challenges, changing treatment
BioPharma Dive
Tue, 04/13/21 - 10:05 pm
Gilead Sciences
COVID-19
remdesivir
Veklury
clinical trials
Feds call halt to Johnson & Johnson COVID-19 vaccine rollout after 'extremely rare' blood clot cases
Fierce Pharma
Tue, 04/13/21 - 10:41 am
JNJ
vaccines
blood clots
COVID-19
FDA
CDC
With variants spreading, Eli Lilly cuts solo COVID-19 antibody out of its U.S. supply deal
Fierce Pharma
Tue, 04/13/21 - 10:35 am
Eli Lilly
COVID-19
antibodies
bamlanivimab-etesevimab
Diasorin heads to the US with $1.8bn Luminex deal
EP Vantage
Tue, 04/13/21 - 10:15 am
Diasorin Molecular
Luminex
diagnostics
M&A
COVID-19
Will Worse Side Effects for Moderna's Vaccine Boost Pfizer's Fortunes?
Motley Fool
Tue, 04/13/21 - 10:13 am
vaccines
COVID-19
Moderna Therapeutics
Pfizer
BioNTech
side effects
COVID player and Pfizer-partnered Valneva eyes $100M Nasdaq IPO
Fierce Biotech
Mon, 04/12/21 - 11:25 pm
Valneva
IPOs
COVID-19
Pfizer
India axes exports of Gilead Sciences' remdesivir, plots boost to local production as COVID cases mount: reports
Fierce Pharma
Mon, 04/12/21 - 10:59 pm
India
drug manufacturing
Gilead Sciences
remdesivir
COVID-19
Regeneron’s Covid mAb as a prophylactic injection: Reduced risk of symptomatic infection by 81%
Endpoints
Mon, 04/12/21 - 11:09 am
Regeneron
monoclonal antibodies
NIH
COVID-19
CEOs of COVID-19 Vaccine Makers See Boost in Salaries
BioSpace
Mon, 04/12/21 - 11:00 am
Pharma CEOs
COVID-19
executive pay
Albert Bourla
Pfizer
Ugur Sahin
BioNTech
Stephane Bancel
Moderna Therapeutics
Alex Gorsky
JNJ
Pascal Soriot
AstraZeneca
FDA joins Europe in probing rare blood clots after Johnson & Johnson's COVID-19 vaccine
Fierce Pharma
Mon, 04/12/21 - 10:45 am
FDA
JNJ
COVID-19
vaccines
blood clots
AstraZeneca’s Farxiga fails phase 3 COVID-19 test
Pharmaforum
Mon, 04/12/21 - 10:33 am
AstraZeneca
diabetes
heart failure
Farxiga
COVID-19
clinical trials
Pfizer, BioNTech seek U.S. emergency nod for COVID-19 vaccine in adolescents
Yahoo/Reuters
Sun, 04/11/21 - 11:44 pm
Pfizer
BioNTech
vaccines
COVID-19
FDA
Emergency Use Authorization
South African variant may evade protection from Pfizer vaccine, Israeli study says
Yahoo/Reuters
Sun, 04/11/21 - 11:33 pm
Pfizer
BioNTech
vaccines
COVID-19
COVID-19 variants
Scientists work toward an elusive dream: a simple pill to treat Covid-19
Stat
Fri, 04/9/21 - 10:56 am
COVID-19
drug development
Merck
Ridgeback Biotherapeutics
molnupiravir
Pfizer
Atea Pharmaceuticals
EU seeks new contract with Pfizer for up to 1.8 bln vaccines from 2022
Yahoo/Reuters
Fri, 04/9/21 - 10:53 am
Europe
vaccines
Pfizer
BioNTech
COVID-19
Orthopaedic surgeons see slow volume recovery from COVID-19, tip Stryker to gain in poll
Medtech Dive
Fri, 04/9/21 - 10:45 am
Orthopedic
Smith & Nephew
Stryker
COVID-19
pandemic
devices
Johnson & Johnson's COVID-19 vaccine under scrutiny at EMA after 4 'serious cases' of unusual blood clots
Fierce Pharma
Fri, 04/9/21 - 10:43 am
JNJ
vaccines
blood clots
EMA
Europe
COVID-19
Some health systems pausing J&J vaccinations after adverse patient reactions
Beckers Hospital Review
Fri, 04/9/21 - 10:41 am
JNJ
vaccines
COVID-19
adverse reactions
Biogen adds a late-stage prospect to its growing biosimilar business
BioPharma Dive
Thu, 04/8/21 - 07:44 pm
Biogen
Actemra
anti-inflammatories
biosimilars
COVID-19
Lilly claims promising finding in failed study of COVID-19 drug
BioPharma Dive
Thu, 04/8/21 - 07:40 pm
Eli Lilly
Incyte
COVID-19
baricitinib
Pages
« first
‹ previous
…
76
77
78
79
80
81
82
83
84
…
next ›
last »